Clinical Trial

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction

Study acronym: STACI
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2023-05-12; most recent amendment 2026-02-06.
Status change: Recruiting → Active, Not Recruiting 2024-12-05
Trial Details
NCT Number NCT05870488
Lead Sponsor SI-BONE, Inc.
Conditions Sacroiliac Joint Dysfunction, Sacroiliac; Fusion, Sacroiliac Disorder, Sacroiliac Joint Pain
Enrollment 110 participants
Start Date 2023-05-23
Primary Completion 2025-04-23 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-06